Regenxbio Inc (RGNX)
9.18
-0.45
(-4.67%)
USD |
NASDAQ |
Nov 21, 16:00
9.25
+0.07
(+0.76%)
After-Hours: 20:00
Regenxbio Market Cap: 454.82M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 454.82M |
| November 20, 2024 | 477.12M |
| November 19, 2024 | 473.65M |
| November 18, 2024 | 502.88M |
| November 15, 2024 | 477.12M |
| November 14, 2024 | 551.93M |
| November 13, 2024 | 528.65M |
| November 12, 2024 | 519.73M |
| November 11, 2024 | 572.74M |
| November 08, 2024 | 552.92M |
| November 07, 2024 | 554.41M |
| November 06, 2024 | 467.21M |
| November 05, 2024 | 441.94M |
| November 04, 2024 | 434.02M |
| November 01, 2024 | 435.50M |
| October 31, 2024 | 425.59M |
| October 30, 2024 | 437.88M |
| October 29, 2024 | 448.78M |
| October 28, 2024 | 464.63M |
| October 25, 2024 | 463.14M |
| October 24, 2024 | 474.54M |
| October 23, 2024 | 482.46M |
| October 22, 2024 | 475.03M |
| October 21, 2024 | 513.67M |
| October 18, 2024 | 549.83M |
| Date | Value |
|---|---|
| October 17, 2024 | 525.06M |
| October 16, 2024 | 532.49M |
| October 15, 2024 | 510.20M |
| October 14, 2024 | 505.25M |
| October 11, 2024 | 489.89M |
| October 10, 2024 | 460.17M |
| October 09, 2024 | 457.69M |
| October 08, 2024 | 473.54M |
| October 07, 2024 | 471.56M |
| October 04, 2024 | 481.47M |
| October 03, 2024 | 463.14M |
| October 02, 2024 | 491.38M |
| October 01, 2024 | 505.74M |
| September 30, 2024 | 519.61M |
| September 27, 2024 | 533.77M |
| September 26, 2024 | 527.84M |
| September 25, 2024 | 535.25M |
| September 24, 2024 | 554.03M |
| September 23, 2024 | 576.77M |
| September 20, 2024 | 577.76M |
| September 19, 2024 | 617.79M |
| September 18, 2024 | 619.27M |
| September 17, 2024 | 640.03M |
| September 16, 2024 | 629.65M |
| September 13, 2024 | 634.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
425.59M
Minimum
Oct 31 2024
2.117B
Maximum
Jan 14 2021
1.137B
Average
1.088B
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 2.519B |
| EyePoint Pharmaceuticals Inc | 569.90M |
| Cassava Sciences Inc | 1.548B |
| Vertex Pharmaceuticals Inc | 115.98B |
| Sarepta Therapeutics Inc | 10.55B |
Market Cap Related Metrics
| PS Ratio | 5.202 |
| Price to Book Value | 1.509 |
| Price | 9.18 |
| Earnings Yield | -54.68% |